Medical Health & Life Science Research News

Colorectal cancer market was worth $4.14 billion in 2016 and estimated to be growing at a CAGR of 3.40% insights shared in detailed report

Colorectal cancer market was worth $4.14 billion in 2016 and estimated to be growing at a CAGR of 3.40% insights shared in detailed report

Asia-Pacific Colorectal Cancer Market was worth $4.14 billion in 2016 and estimated to be growing at a CAGR of 3.40%, to reach $4.89 billion by 2021.

- Advertising -

Though there has been substantial development in science and technology to combat cancer, it continues to threaten lives across the globe.

Colorectal cancer results due to unrestrained cell growth that occurs in the appendix, colon, and the rectum region. Colorectal cancer is identified with a biopsy, which then followed by medical imaging to know its extent.

Depending on the stage and how much the cancer has expanded, a combination of radiation therapy, chemotherapy, and targeted therapy is recommended by most oncologists.

- Advertising -

Browse market data tables and in-depth TOC of the Asia-Pacific Colorectal Cancer Market to 2021 @ www.marketdataforecast.com/market-…ancer-market-613/

The growth of the Asia-Pacific Colorectal Cancer market is mainly due to the rise in aging population, and increasing awareness towards colorectal Cancer. However, poor accessibility of proper care, volatile economies and lack of awareness in this part of the world are the key factors hindering the growth of the market in this region.

Free sample of the report is available @ www.marketdataforecast.com/market-…13/request-sample

The Asia-Pacific Colorectal Cancer market is segmented based on Diagnosis and Treatment. The market for Colorectal Cancer, on the basis of Diagnosis is segmented into Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy.

On the basis of Treatment, the global Colorectal Cancer market is segmented into Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies.

Inquire report @ www.marketdataforecast.com/market-…arket-613/inquire

The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. The Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to reasons such as rising aging population and increasing participation of several private & public establishments to organize awareness programs on colorectal Cancer.

China is the largest market for Colorectal Cancer in this region followed by India. Indonesia, Vietnam, and Malaysia, are some of the significant players in this market.

Avail report @ www.marketdataforecast.com/market-…/request-discount

The major companies dominating the market in this region are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD.

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...